TERM ID="NYU_TERM_1" STRING="Antidiabetes agents" FREQUENCY=1 START=1110 END=1129 LEMMA="ANTIDIABETES AGENT" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_2" STRING="DPP-4" FREQUENCY=1 START=1184 END=1189 LEMMA="DIPEPTIDYL PEPTIDASE 4" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_3" STRING="GLP-1" FREQUENCY=1 START=1231 END=1236 LEMMA="GLUCAGON LIKE PEPTIDE 1" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_4" STRING="GLP-1 receptor" FREQUENCY=1 START=1325 END=1339 LEMMA="GLP-1 RECEPTOR" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_5" STRING="antihyperglycemic treatment strategies" FREQUENCY=1 START=8 END=46 LEMMA="ANTIHYPERGLYCEMIC TREATMENT STRATEGY" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_6" STRING="beta-cell dysfunction" FREQUENCY=1 START=993 END=1014 LEMMA="BETA-CELL DYSFUNCTION" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_7" STRING="cardiovascular disease" FREQUENCY=1 START=371 END=393 LEMMA="CARDIOVASCULAR DISEASE" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_8" STRING="cardiovascular risk" FREQUENCY=1 START=763 END=782 LEMMA="CARDIOVASCULAR RISK" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_9" STRING="cardiovascular risk markers" FREQUENCY=1 START=1429 END=1456 LEMMA="CARDIOVASCULAR RISK MARKER" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_10" STRING="derangements" FREQUENCY=1 START=1050 END=1062 LEMMA="DERANGEMENT" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_11" STRING="diabetes mellitus" FREQUENCY=1 START=143 END=160 LEMMA="DIABETES MELLITUS" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_12" STRING="dipeptidyl peptidase-4" FREQUENCY=2 START=1160 END=1182 LEMMA="DIPEPTIDYL PEPTIDASE-4" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_13" STRING="dipeptidyl peptidase-4" FREQUENCY=2 START=1160 END=1182 LEMMA="DIPEPTIDYL PEPTIDASE-4" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_14" STRING="dyslipidemia" FREQUENCY=2 START=283 END=295 LEMMA="DYSLIPIDEMIA" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_15" STRING="dyslipidemia" FREQUENCY=2 START=705 END=717 LEMMA="DYSLIPIDEMIA" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_16" STRING="excessive weight" FREQUENCY=2 START=115 END=131 LEMMA="EXCESSIVE WEIGHT" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_17" STRING="excessive weight" FREQUENCY=2 START=662 END=678 LEMMA="EXCESSIVE WEIGHT" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_18" STRING="glucagon-like peptide-1" FREQUENCY=2 START=1206 END=1229 LEMMA="GLUCAGON-LIKE PEPTIDE-1" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_19" STRING="glucagon-like peptide-1" FREQUENCY=2 START=1206 END=1229 LEMMA="GLUCAGON-LIKE PEPTIDE-1" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_20" STRING="glycemic control" FREQUENCY=1 START=417 END=433 LEMMA="GLYCEMIC CONTROL" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_21" STRING="hyperglycemia" FREQUENCY=1 START=1310 END=1323 LEMMA="HYPERGLYCEMIA" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_22" STRING="incretin system" FREQUENCY=1 START=1070 END=1085 LEMMA="INCRETIN SYSTEM" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_23" STRING="macro vascular complications" FREQUENCY=1 START=567 END=595 LEMMA="MACRO VASCULAR COMPLICATION" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_24" STRING="microvascular complications" FREQUENCY=1 START=481 END=508 LEMMA="MICROVASCULAR COMPLICATION" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_25" STRING="pathophysiologic defects" FREQUENCY=1 START=939 END=963 LEMMA="PATHOPHYSIOLOGIC DEFECT" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_26" STRING="peripheral insulin resistance" FREQUENCY=1 START=1019 END=1048 LEMMA="PERIPHERAL INSULIN RESISTANCE" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_27" STRING="receptor agonists" FREQUENCY=1 START=1238 END=1255 LEMMA="RECEPTOR AGONIST" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_28" STRING="risk factors" FREQUENCY=1 START=621 END=633 LEMMA="RISK FACTOR" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_29" STRING="weight loss" FREQUENCY=2 START=843 END=854 LEMMA="WEIGHT LOSS" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_30" STRING="weight loss" FREQUENCY=2 START=1374 END=1385 LEMMA="WEIGHT LOSS" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_31" STRING="weight neutrality" FREQUENCY=1 START=822 END=839 LEMMA="WEIGHT NEUTRALITY" LEMMA_FREQUENCY=1
